Michael F. Neidorff
Chairman and Chief Executive Officer at Centene
Thank you, Jennifer. Good morning, and thank you joining Centene's Third Quarter Earnings call. As you will notice today, we are evolving our presentation's format to a streamline version and with essential facts and commentary. I'm pleased to have Sarah London and Drew Asher joining me today. Brent Layton has a conflict that could not be avoided, but you can expect him to join us on future calls. First, on the quarter, we were pleased with the results and the fact that the matrix was straightforward with minimum noise. In the quarter, we generated revenue of $32.4 billion and HBR of 88.1% and adjusted earnings per share of $1.26. Drew, provide additional context.
Overall, the numbers reflect a return to a normal utilization while still covering reasonable amounts of COVID costs which seem to have peaked in August. Importantly, our performance provides a strong foundation for our value creation plan and we remain committed to our margin goals. Further supporting our strategic progress during the quarter, we announced a series of organizational changes including a point Sarah London as Vice Chairman of the Board of Directors and Brent Layton as the company's President and Chief Operating Officer.
I would also like to acknowledge that David Steward, an 18-year veteran of our Board of Directors retire to pursue personal business interests. We do not plan to replace his position, as we continue to work on refreshing and streamline the Board to a size of 9 to 13 members. Turning to the current landscape. Overall, the portfolio is performing well. We delivered a strong membership increase in Medicaid are positioned for continued growth in Medicare and we continue to stay the course in marketplace. Sarah, will provide further detail. We are working closely with states and the timing redetermination, which has so far been extended until January with the opportunity for additional extensions three months at a time.
As redeterminations to resume, I would like to remind you that not all states will be doing so at the center. In addition, we look forward to offer members who will no longer qualify for Medicaid, the opportunity to enroll in our marketplace for us. We expect that advanced premium tax credits will keep costs in line for these members, and we value the opportunity support continuity of care and preserve, provide relationships which in the long-term leads to higher quality care, which is much more cost effective.
Looking ahead of 2022, there are several additional factors we continue to monitor and evaluate. These include the pace of the RFP pipeline, ongoing growth in Medicare, the opportunity for improvement in marketplace license, as well as the COVID landscape overall. We will provide full details on these factors and their potential impacts, as headwinds and tailwinds at our Investor Day in December.
In addition, we are committed to achieving an investment grade rating and a disciplined capital allocation framework that takes into consideration our priorities including investing in our business debt management and share repurchases. Before I close, I would like to highlight the importance of vaccine mandates in stopping the transmission of COVID and protecting those who cannot yet safely receive inoculations, particularly the immunologically compromised, and young children for whom vaccine access is getting closer, but still pending.
Centene has been a leader on this critical issue mandating vaccinations, as an additional employment. We also continue to support our members in assessing the vaccine to a national outreach and campaigns and creative participation such as the Pro Football Hall of Fame NESCO. I would also like to remind you that this platform for vaccines has been in development for the past 25 years and scientists are indicating is likely, one of the safest vaccines ever developed. In closing, we are pleased with our third quarter results and has the same momentum across the enterprise. We remain focused on executing across the value creation playbook, we have in place. As always, we intend and continue to provide transparent updates, as we progress through our initiatives and I look forward to seeing many of you at our December Investor Day. Finally, I would like to thank all our employees for their unwavering commitment and service throughout this unprecedented time. Thank you for your continued interest in Centene, and would turn the call over to Sarah.